OACC
Oaktree Acquisition Corp. III Life Sciences
OACC is Oaktree Acquisition Corp. III Life Sciences, a special purpose acquisition company listed on NASDAQ. It raised $175.0M at $10.00 a unit on 24 Oct 2024 and has been looking for a target for 1y 9m. Its shares last closed at $10.80, +8.00% against the $10.00 issue price. Cash in trust per share, the charter deadline and the size of the sponsor’s promote are not published here yet — those three come out of the SPAC’s own filings.
The offering
The market
As at 2026-08-14.
Last filed balance sheet
A SPAC’s public shares are redeemable, so these lines do not net out the way an operating company’s do — and none of them is the trust. For a SPAC that listed this quarter the sheet on file predates the IPO entirely.
From the filings
The three figures this site is being built to publish, and the three no market data feed can answer. They are read off each SPAC's prospectus, charter and quarterly reports, and until that pipeline lands they read N/A rather than being filled in from something adjacent. What each one means.
Identifiers
Listing and market figures as at 2026-08-14, from the dataset behind the screener. Not a recommendation — see the disclaimer.
Know which date decides what you get.
The redemption election closes before the vote, and it is the one that returns cash. The lifecycle page walks the whole sequence.